Imiquimod Topical Cream 3.75% + Zyclara® (imiquimod) Topical Cream 3.75% + Vehicle Topical Cream
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Actinic Keratosis
Conditions
Actinic Keratosis
Trial Timeline
Jan 1, 2013 → Dec 1, 2013
NCT ID
NCT01788007About Imiquimod Topical Cream 3.75% + Zyclara® (imiquimod) Topical Cream 3.75% + Vehicle Topical Cream
Imiquimod Topical Cream 3.75% + Zyclara® (imiquimod) Topical Cream 3.75% + Vehicle Topical Cream is a phase 1 stage product being developed by Sun Pharmaceutical for Actinic Keratosis. The current trial status is completed. This product is registered under clinical trial identifier NCT01788007. Target conditions include Actinic Keratosis.
What happened to similar drugs?
6 of 20 similar drugs in Actinic Keratosis were approved
Approved (6) Terminated (1) Active (14)
🔄Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl), 20%Sun PharmaceuticalPhase 3
🔄Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl), 20%Sun PharmaceuticalPhase 3
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01788007 | Phase 1 | Completed |
Competing Products
20 competing products in Actinic Keratosis